In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...
New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), ...
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...
9 In addition to its application in infectious diseases, there are several CRISPR-based developments for the diagnosis of other diseases, including cancer, where it is being used to detect cancer ...
It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still ... in Beijing and his colleagues used CRISPR to create the mice, using a novel ...
Innovative synthetic biology techniques are revolutionizing microbiota-based therapies, enhancing microbial functions for improved health and disease treatment.
20d
Hosted on MSNVertex Down 13% in 6 Months: Buy, Sell or Hold the Stock?The stock of Vertex Pharmaceuticals Incorporated VRTX has declined almost 13% in the past six months. A key reason for the stock price decline was unimpressive data from a phase II study on its key ...
Kennedy Jr. will divest his interests in several biopharma companies, including CRISPR Therapeutics and Dragonfly Therapeutics, if confirmed by the ...
The Durban University of Technology (DUT) has reiterated that it does not permit walk-in applications for the 2025 academic year. The institution has emphasised that its application deadline ...
Department of Chemical and Biomolecular Engineering (BK21 Four), Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea ...
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results